Event-Free Survival Extended With Long-Term Finerenone in Heart Failure

MONDAY, Sept. 30, 2024-- Long-term treatment with finerenone is estimated to extend event-free survival among people with heart failure with mildly reduced or preserved ejection fraction, according to a brief report published online Sept. 27 in...